Alixorexton: The FDA Fast-Tracked Drug Set to Revolutionize Narcolepsy Treatment
Discover Alixorexton, a promising oral orexin 2 receptor agonist granted FDA Breakthrough Therapy designation. Learn about its groundbreaking clinical trial results for narcolepsy type 1 and 2.